Clearstead Advisors’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Other funds holding XERS
RA
Clearstead Advisors's XERS Position: Q2 2026 in Review
Clearstead Advisors opened a new position in Xeris Biopharma Holdings (XERS) in Q2 2026: 146 shares worth $1.16K. The stake represents ﹤0.01% of the portfolio and ranks #2651 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in XERS as recently as Q4 2025.
Clearstead Advisors first reported a position in XERS in Q2 2025 and has held it in 4 quarters since. The position peaked at $4.73K in Q3 2025. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.
- Clearstead Advisors held 146 shares of Xeris Biopharma Holdings worth $1.16K as of Q2 2026.
- Xeris Biopharma Holdings was a new Clearstead Advisors position in Q2 2026.
- Xeris Biopharma Holdings made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2651 holding.
- Clearstead Advisors first reported a position in Xeris Biopharma Holdings in Q2 2025 and has held it in 4 quarters since.
- Clearstead Advisors's Xeris Biopharma Holdings position peaked at $4.73K in Q3 2025.
- 241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.
Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.